Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 01, 2010 09:47 ET | Source: Oxigene, Inc.

OXiGENE tillkännager offentliggörandet av prekliniska uppgifter om OXi4503

Södra San Francisco, Kalifornien, 1 juni, 2010 (GLOBE Newswire) -- OXiGENE, Inc. (Nasdaq: OXGN) (Stockholm: OXGN), ett biopharma företag som strävar efter att upptäcka och utveckla nya och förbättrade...
May 27, 2010 08:00 ET | Source: Oxigene, Inc.

OXiGENE Announces Publication of Preclinical Data on OXi4503 Demonstrating Potent Anti-Leukemic Effects

SOUTH SAN FRANCISCO, Calif., May 27, 2010 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer...
May 18, 2010 16:00 ET | Source: Oxigene, Inc.

OXiGENE Announces Clinical Data to be Presented at the 2010 Annual Meeting of the American Society of Clinical Oncology

SOUTH SAN FRANCISCO, Calif., May 18, 2010 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer...
May 11, 2010 16:33 ET | Source: Oxigene, Inc.

OXiGENE Reports First Quarter 2010 Financial Results

SOUTH SAN FRANCISCO, Calif., May 11, 2010 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer...
May 05, 2010 08:00 ET | Source: Oxigene, Inc.

OXiGENE Announces First Quarter 2010 Earnings Conference Call and Webcast

SOUTH SAN FRANCISCO, Calif., May 5, 2010 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and...
April 23, 2010 02:00 ET | Source: Oxigene, Inc.

OXiGENE Applies for Voluntary Delisting From the Stockholm Exchange

SOUTH SAN FRANCISCO, Calif., April 23, 2010 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases,...
April 07, 2010 02:00 ET | Source: Oxigene, Inc.

OXiGENE Regains Compliance With NASDAQ Listing Requirements

SOUTH SAN FRANCISCO, Calif., April 7, 2010 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases,...
April 05, 2010 08:00 ET | Source: Oxigene, Inc.

OXiGENE Appoints Tamar D. Howson and Peter J. Langecker to Its Board of Directors

SOUTH SAN FRANCISCO, Calif., April 5, 2010 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases,...
March 19, 2010 08:00 ET | Source: Oxigene, Inc.

OXiGENE Announces Going Concern Opinion On Its Audited Financial Statements for 2009

SOUTH SAN FRANCISCO, Calif., March 19, 2010 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases,...
March 15, 2010 08:00 ET | Source: Oxigene, Inc.

OXiGENE Announces Change to Board of Directors

SOUTH SAN FRANCISCO, Calif., March 15, 2010 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases,...